Generated: May 29, 2017
|Title:||Treatment of a latent infection of herpes viruses|
|Abstract:||A method for the treatment of latent infection of herpesviruses in mammals, including humans, which method comprises administering to the mammal in need of such treatment, an effective amount of a compound of formula (A): ##STR1## or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing.|
|Inventor(s):||Field; Hugh John (Cambridge, GB2), Thackray; Alana Maureen (Cambridge, GB2), Bacon; Teresa Helen (Weybridge, GB2), Sutton; David (Wayne, PA), Vere Hodge; Richard Anthony (Reigate, GB2)|
|Assignee:||SmithKline Beecham plc (Brentford, GB)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|United Kingdom||9425012||► Subscribe|
|European Patent Office||0799039||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.